Browse > Article
http://dx.doi.org/10.3345/kjp.2008.51.12.1290

Epilepsy in various metabolic disorders  

Lee, Young-Mock (Department of Pediatrics, Yonsei University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.51, no.12, 2008 , pp. 1290-1294 More about this Journal
Abstract
Seizures are a frequent symptom in metabolic disorders, although metabolic disorders are rarely found to be the cause of epilepsy. A precise diagnosis might not only influence treatment, but it might also call for counseling of the family, even if there are no direct therapeutic consequences. We review the main characteristics of epilepsy in metabolic disorders with regard to energy metabolism, toxic effects, neurotransmitters, and vitamins.
Keywords
Epilepsy; Seizure; Metabolic Disorder;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pearl PL, Bennett HD, Khademian Z. Seizures and metabolic disease. Curr Neurol Neurosci 2005;5:127-33   DOI   ScienceOn
2 Wolf NI, Bast T, Surtees R. Epilepsy in inborn errors of metabolism. Epileptic Disord 2005;7:67-81
3 Thomson AM. Glycine is a coagonist at the NMDA receptor/ channel complex. Prog Neurobiol 1990;35:53-74   DOI   ScienceOn
4 Gropman A. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency. Ann Neurol 2003;54 (6 Suppl):66S-72S   DOI   ScienceOn
5 Sadleir LG, Connolly MB, Applegarth D, Hendson G, Clarke L, Rakshi C, et al. Spasms in children with definite and probable mitochondrial disease. Eur J Neurol 2004;11:103-10   DOI   ScienceOn
6 Baxter P, Griffiths P, Kelly T, Gardner-Medwin D. Pyridoxinedependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 1996;38:998-1006   DOI   ScienceOn
7 Salbert BA, Pellock JM, Wolf B. Characterization of seizures associated with biotinidase deficiency. Neurology 1993;43: 1351-5   DOI   ScienceOn
8 Kang HC, Lee YM, Kim HD, Lee JS, Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007;48:82-8
9 Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatinedeficiency syndrome. Am J Hum Genet 2001;68:1497-500   DOI   ScienceOn
10 Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol 2001;49:377-83   DOI   ScienceOn
11 Kunz WS. The role of mitochondria in epileptogenesis. Curr Opin Neurol 2002;15:179-84   DOI   ScienceOn
12 Brockmann K, Wang D, Korenke CG, von Moers A, Ho YY, Pascual JM, et al. Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol 2001;50:476-85   DOI   ScienceOn
13 Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP, et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005;57:111-8   DOI   ScienceOn
14 Yanling Y, Qiang G, Zhixiang Z, Chunlan M, Lide W, Xiru W. A clinical investigation of 228 patients with phenylketonuria in mainland China. Southeast Asian J Trop Med Public Health 1999;30(2 Suppl):58S-60S
15 Zschocke J, Ruiter JP, Brand J, Lindner M, Hoffmann GF, Wanders RJ, et al. Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatr Res 2000;48:852-5   DOI   ScienceOn
16 Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 1998;132:709-13   DOI   ScienceOn
17 Anne T. Berg. Epidemiologic Aspects of Epilepsy. In: Wyllie E. The treatment of epilepsy. 4th edition. Philadelphia: Lippincott Williams & Wilkins, 2006:109-16
18 Schulze A, Bachert P, Schlemmer H, Harting I, Polster T, Salomons GS, et al. Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 2003;53:248-51   DOI   ScienceOn
19 Van Kuilenburg AB, Vreken P, Abeling NG, Bakker HD, Meinsma R, Van Lenthe H, et al. Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet 1999;104:1-9   DOI
20 Clayton PT, Surtees RA, DeVile C, Hyland K, Heales SJ. Neonatal epileptic encephalopathy. Lancet 2003;361:1614   DOI   ScienceOn
21 Schulze A, Ebinger F, Rating D, Mayatepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 2001;74:413-9   DOI   ScienceOn
22 Jaeken J. Genetic disorders of gamma-aminobutyric acid, glycine, and serine as causes of epilepsy. J Child Neurol 2002;17(3 Suppl):84S-87S
23 Cormier-Daire V, Dagoneau N, Nabbout R, Burglen L, Penet C, Soufflet C, et al. A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31. Am J Hum Genet 2000;67: 991-3   DOI   ScienceOn
24 Seidner G, Alvarez MG, Yeh JI, O'Driscoll KR, Klepper J, Stump TS, et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998;18:188-91   DOI   ScienceOn
25 Klepper J, Fischbarg J, Vera JC, Wang D, De Vivo DC. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr Res 1999;46:677-83   DOI   ScienceOn
26 Torres OA, Miller VS, Buist NM, Hyland K. Folinic acidresponsive neonatal seizures. J Child Neurol 1999;14:529-32   DOI
27 Collins JE, Nicholson NS, Dalton N, Leonard JV. Biotinidase deficiency: early neurological presentation. Dev Med Child Neurol 1994;36:268-70   DOI   ScienceOn
28 So N, Berkovic S, Andermann F, Kuzniecky R, Gendron D, Quesney LF. Myoclonus epilepsy and ragged-red fibres (MERRF). 2. Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain 1989;112: 1261-76   DOI   ScienceOn
29 Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, et al. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 2003;60: 1413-7   DOI   ScienceOn
30 Lee YM, Kang HC, Lee JS, Kim SH, Kim EY, Lee SK, et al. Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia 2008;49:685-90   DOI   ScienceOn
31 Castro M, Prez-CerdC, Merinero B, Garca MJ, Bernar J, Gil Nagel A, et al. Screening for adenylosuccinate lyase deficiency: clinical, biochemical and molecular findings in four patients. Neuropediatrics 2002;33:186-9   DOI   ScienceOn
32 Stockler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura K. Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 1996;58:914-22
33 Applegarth DA, Toone JR. Glycine encephalopathy (nonketotic hyperglycinaemia): review and update. J Inherit Metab Dis 2004;27:417-22   DOI